Midlife weight gain is a persistent challenge for many women, but emerging research suggests hormone therapy may enhance response to glucagon-like peptide-1 (GLP-1)–based treatments.
The Houthi rebels have detained two additional United Nations staff members and raided the homes of several others in Yemen ...
People, I think, have started looking outside the box when it comes to health care. And they’re turning more to wellness and ...
Novo Nordisk faces headwinds and leadership shifts, while Structure Therapeutics eyes pivotal obesity-drug data later this year.
CHICAGO -- A series of large, real-world analyses supported benefit of GLP-1 receptor agonists in cardiopulmonary indications for patients with type 2 diabetes, researchers reported at the CHEST ...
Researchers at Virginia Polytechnic Institute and State University took 20 people living with obesity (half on GLP-1s like ...
The approval was based on the SOUL trial, which evaluated oral semaglutide in adults 50 years and older with T2DM and ...
Incessant and debilitating thoughts about food seem to be a common experience for people with obesity. Telehealth giant Ro ...
NileRed on MSN
I Made a Bismuth Knife Because Therapy Was Too Expensive
When life gives you chaos, melt something shiny. I forged a knife out of bismuth — fragile, colorful, and entirely ...
Using semaglutide or tirzepatide for less than 2 years can cost as much as a Roux-en-Y gastric bypass — a one-time procedure ...
Weight loss medications can be lifesaving for people who need them — but there are errors you’ll want to avoid.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback